UCSF

Tagged: Food and Drug Administration (FDA)

UCSF study: Drug information resources may miss parts of boxed warnings

An analysis by UCSF faculty members from the Schools of Pharmacy and Medicine has found that the half-dozen most reputable electronic drug information resources—tools commonly used by clinicians to make prescription and patient monitoring decisions—may not provide key elements of some medications’ black box warnings.

Prioritizing drug label warnings called for by UCSF School of Pharmacy authors

In the current issue of The Archives of Internal Medicine, two faculty members of the UCSF School of Pharmacy, Department of Clinical Pharmacy issue a call for prioritization in prescription labels’ increasingly long lists of adverse drug events (ADEs).

Symposium on the future of therapeutics inaugurates new UCSF department

In the first symposium held by the newly minted UCSF Department of Bioengineering and Therapeutic Sciences, researchers described progress in the fields of systems biology, pharmacogenomics, and bioengineering, and how scientists in these fields are working in concert to develop novel diagnostics and therapeutics to effectively and safely diagnose and treat disease.

Study Identifies Lack of Information about HER2 Testing Practices

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of HER2, trastuzumab can be highly effective.

Soller Comments on Acetaminophen

William Soller, PhD, UCSF faculty member and expert on food and drug law and regulations comments on the June 30, 2009 vote of a US Food and Drug Administration (FDA) advisory committee to lower the US maximum over-the-counter dose of acetaminophen and make the current maximum single dose of the drug be available by prescription only.

Plan B Under Review Again by the FDA

In light of the US Food and Drug Administration (FDA) July 31, 2006 announcement that it is proceeding to work toward making emergency contraception, known as Plan B, a non-prescription product for women ages 18 and older, two UCSF School of Pharmacy clinical faculty members answer questions about the contraceptive and surrounding policy issues.

Antivirals and the Avian Flu

While a number of antiviral medications are used to combat typical types of influenza, only 2 are active against the new avian influenza virus, known as H5N1, according to Joseph Guglielmo, PharmD, UCSF School of Pharmacy professor and clinical pharmacist specializing in medications to treat infectious diseases.

Industry Data Should Be Shared

The same level of legal scrutiny that applies to research funded by the US government should apply to research funded by industry, according to UCSF School of Pharmacy faculty member Lisa Bero, PhD, and co-authors of a study that appeared July 20, 2005 in the online issue of American Journal of Public Health.

Pages